MedTrace Logo

Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia

NCT01819792 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2018-04-23

No results posted yet for this study

Summary

Infectious morbidity and mortality is a major complication of AML (Acute Myeloid Leukemia) induction and consolidation chemotherapies related aplasia. The main aim of this study is to measure incidence of respiratory viral infections during AML induction and consolidation chemotherapy related aplasia. Primary end point is a positive polymerase chain reaction(PCR)associated with clinical signs.

Conditions

Interventions

OTHER

Multiplex respiratory viral PCR

Sponsors & Collaborators

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Principal Investigators

  • Jean Pierre MAROLLEAU, MD PHD · CHU AMIENS

  • FABRICE JARDIN, MD PHD · CHU ROUEN

  • OUMEDALY RENAN, MD PHD · CHU CAEN

  • BRUNO QUESNEL, MD PHD · CHRU LILLE

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01819792 on ClinicalTrials.gov